Comparative Clinical Outcomes Of Panoptix Pro And Panoptix Intraocular Lenses.

To compare visual performance and patient-reported outcomes between PanOptix Pro and PanOptix trifocal intraocular lenses (IOLs) in patients undergoing routine cataract surgery.

Sydney, Australia

In this prospective comparative study, 40 patients (80 eyes) undergoing bilateral cataract surgery were enrolled at a single center and assigned to receive either the PanOptix Pro (n = 20 patients) or PanOptix (n = 20 patients) IOL.  At 3 months postoperatively, binocular uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA; 80 cm), and uncorrected near visual acuity (UNVA; 40 cm) will be assessed using logMAR notation. Defocus curves will be obtained from +1.50 D to −4.00 D in 0.50 D increments. Contrast sensitivity will be measured under photopic conditions. Patients will completed a quality-of-life questionnaire evaluating spectacle independence, dysphotopsia, and overall satisfaction.

Patient enrollment and follow-up are ongoing. At the time of submission, data collection has not been completed; therefore, comparative analyses between the PanOptix Pro and PanOptix trifocal intraocular lenses cannot yet be performed. No interim efficacy analyses have been conducted. To date, no unexpected safety concerns have been identified. Final analyses of visual acuity outcomes and patient-reported measures will be completed after database lock, and results will be presented at the meeting.

This ongoing study is designed to compare visual performance and patient-reported outcomes between PanOptix Pro and PanOptix trifocal intraocular lenses in routine cataract surgery. Final efficacy and safety results are pending completion of data collection and statistical analysis and will clarify potential differences in visual outcomes and patient satisfaction between the two lenses.